Fluoxetine for obsessive-compulsive disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 Oct 2019: Trial started, NCT04131829
  2. 18 Oct 2019: Trial registered, NCT04131829

The trials

NCT04131829: Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD

State
Under way
Phase
Phase 1 and Phase 2
People
100 planned
Started
14 Oct 2019
Primary completion
Sep 2027
Arms
OCD Group
Results
None posted
  1. 14 Oct 2019: Trial started
  2. 18 Oct 2019: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Also known as Antidepressant medication (fluoxetine), Fluoxetine 20 MG, fluoxetine (Prozac).

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.